The Trump administration has announced a major expansion of its drug pricing initiative by striking deals with nine more pharmaceutical giants, framing the development as a historic victory for American consumers that will turn a bold policy into an industry standard. Administration officials claim
With a career spanning the highest echelons of policy and legislation, Donald Gainsborough, head of Government Curated, offers a rare look inside the complex machinery of U.S. health policy. His insights pull back the curtain on the recent, tumultuous internal debates at the Department of Health
The familiar sound of sirens now carries an undertone of uncertainty as England's National Health Service grapples with an industrial action of unprecedented scale. A five-day strike by resident doctors has brought the public healthcare system to a critical inflection point, exposing deep-seated
A Political Time Bomb Ticking in the GOP The December 31 expiration of enhanced Affordable Care Act (ACA) subsidies has become more than a policy deadline; it is a political time bomb ticking at the heart of the Republican party. With millions of Americans, many in GOP-held districts, facing
As a political savant and leader in policy and legislation at the helm of Government Curated, Donald Gainsborough possesses a unique perspective on the forces shaping Pennsylvania's future. With a massive $90 billion in AI-related investment poised to enter the commonwealth, Gainsborough offers a
With a financial cliff looming that could raise health insurance premiums for 24 million Americans by an average of 26 percent, the nation's leading health insurers have made an unexpected and high-stakes pivot in their lobbying strategy. This story is no longer a simple debate over healthcare
